HCA Healthcare HCA
$475.57 +$15.24 (+3.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $476.00 +0.09%
Open$467.00
Prev close$460.33
Day range$463.50 – $479.77
Volume1.58M
Market cap$99.34B
P/E (TTM)15.8
Dividend yield0.64%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$19.85B+3.6% YoY
Operating profit$2.94B-0.7% YoY
Net profit$1.85B-2.8% YoY
Diluted EPS$7.27+4.5% YoY
Free cash flow$3.10B-0.8% YoY
Operating cash flow$4.46B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin42.8%
Operating margin15.3%
Net margin8.6%
Return on assets11.0%
Current ratio0.82
Liabilities / assets107.2%
Cash & investments$908.00M
Total debt$52.43B
Net cash (debt)-$51.52B
Free cash flow / sales7.6%
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-22 14:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $75.60B | Annual | 2025-12-31 | 2026-02-10 |
| Net income | $6.78B | Annual | 2025-12-31 | 2026-02-10 |
| Operating cash flow | $12.64B | Annual | 2025-12-31 | 2026-02-10 |
| Total assets | $60.72B | Period end | 2025-12-31 | 2026-02-10 |
| Stockholders’ equity | -$6.03B | Period end | 2025-12-31 | 2026-02-10 |
| Cash and cash equivalents | $1.04B | Period end | 2025-12-31 | 2026-02-10 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $19.85B | $20.23B | $19.11B | $75.60B | $19.51B |
| Total Operating Revenue | $19.85B | $20.23B | $19.11B | $75.60B | $19.51B |
| Cost of Revenue | $11.40B | $11.18B | $11.14B | $44.23B | $11.34B |
| Gross Profit | $8.45B | $9.05B | $7.97B | $31.37B | $8.18B |
| Operating Expense | $5.50B | $5.99B | $5.11B | $19.41B | $5.00B |
| Depreciation & Amortization & Depletion | $954.00M | $944.00M | $930.00M | $3.52B | $911.00M |
| -Depreciation & Amortization | $954.00M | $944.00M | $930.00M | $3.52B | $911.00M |
| Other Operating Expenses | $4.55B | $5.04B | $4.18B | $15.89B | $4.09B |
| Operating Profit | $2.94B | $3.07B | $2.86B | $11.97B | $3.18B |
| Net Non-Operating Interest Income (Expense) | -$607.00M | -$599.00M | -$584.00M | -$2.25B | -$572.00M |
| Non-Operating Interest Expense | $607.00M | $599.00M | $584.00M | $2.25B | $572.00M |
| Other Income (Expense) | $33.00M | $26.00M | $8.00M | $115.00M | $66.00M |
| Earnings from Equity Interest | $20.00M | $16.00M | $9.00M | $78.00M | $25.00M |
| Special Income (Charges) | $13.00M | $10.00M | -$1.00M | $37.00M | $41.00M |
| -Gain on Sale Of Business | $13.00M | $10.00M | -$1.00M | $37.00M | $41.00M |
| Pretax Profit | $2.37B | $2.49B | $2.29B | $9.83B | $2.67B |
| Tax | $521.00M | $564.00M | $430.00M | $2.05B | $509.00M |
| Net Profit | $1.85B | $1.93B | $1.86B | $7.78B | $2.16B |
| Profit from Continuing Operations | $1.85B | $1.93B | $1.86B | $7.78B | $2.16B |
| Minority Interests | $270.00M | $231.00M | $237.00M | $998.00M | $285.00M |
| Net Income to Parent Company | $1.58B | $1.70B | $1.62B | $6.78B | $1.88B |
| Net Income to Common Stockholders | $1.58B | $1.70B | $1.62B | $6.78B | $1.88B |
| Basic EPS | $7.36 | $7.70 | $7.25 | $28.70 | $8.36 |
| Diluted EPS | $7.27 | $7.62 | $7.15 | $28.33 | $8.14 |
| Dividend Per Share | $0.78 | $0.78 | $0.78 | $2.88 | $0.72 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $63.45B | $63.25B | $61.45B | $60.72B | $60.72B |
| Total Current Assets | $16.22B | $17.19B | $16.05B | $15.78B | $15.78B |
| Cash and Cash Equivalents & Short-Term Investments | $908.00M | $1.01B | $940.00M | $1.04B | $1.04B |
| -Cash and Cash Equivalents | $908.00M | $1.01B | $940.00M | $1.04B | $1.04B |
| Receivables | $11.51B | $12.28B | $11.32B | $10.87B | $10.87B |
| -Accounts Receivable | $11.51B | $12.28B | $11.32B | $10.87B | $10.87B |
| Inventory | $1.67B | $1.66B | $1.68B | $1.65B | $1.65B |
| Other Current Assets | $2.13B | $2.23B | $2.11B | $2.22B | $2.22B |
| Total Non-Current Assets | $47.23B | $46.06B | $45.40B | $44.94B | $44.94B |
| Net PPE | $34.48B | $33.93B | $33.57B | $33.27B | $33.27B |
| -Gross PPE | $71.84B | $70.52B | $69.46B | $68.41B | $68.41B |
| -Accumulated Depreciation | -$37.36B | -$36.59B | -$35.89B | -$35.13B | -$35.13B |
| Investments and Advances | $1.28B | $1.22B | $1.00B | $1.12B | $1.12B |
| -Long Term Equity Investment | $1.28B | $1.22B | $1.00B | $1.12B | $1.12B |
| Goodwill and Other Intangible Assets | $11.20B | $10.66B | $10.50B | $10.29B | $10.29B |
| Other Non-Current Assets | $280.00M | $258.00M | $326.00M | $255.00M | $255.00M |
| Total Liabilities | $68.05B | $66.46B | $64.43B | $63.49B | $63.49B |
| Total Current Liabilities | $19.78B | $17.31B | $19.26B | $16.35B | $16.35B |
| Payables | $5.10B | $4.75B | $4.81B | $5.16B | $5.16B |
| -Accounts Payable | $5.10B | $4.75B | $4.81B | $4.66B | $4.66B |
| Current Accrued Expenses | $6.58B | $6.30B | $5.92B | $4.97B | $4.97B |
| Short-Term Debt and Capital Lease Obligation | $8.09B | $6.26B | $8.53B | $5.24B | $5.24B |
| -Current Debt | $8.09B | $6.26B | $8.53B | $4.89B | $4.89B |
| Total Non-Current Liabilities | $48.27B | $49.15B | $45.17B | $47.14B | $47.14B |
| Long Term Debt and Capital Lease Obligation | $44.33B | $45.29B | $41.31B | $43.46B | $43.46B |
| -Long Term Debt | $42.40B | $43.45B | $39.49B | $41.60B | $41.60B |
| -Long Term Capital Lease Obligation | $1.93B | $1.83B | $1.82B | $1.85B | $1.85B |
| Other Non-Current Liabilities | $3.94B | $3.86B | $3.86B | $3.69B | $3.69B |
| Total Equity | -$4.60B | -$3.21B | -$2.98B | -$2.77B | -$2.77B |
| Stockholders' Equity | -$8.08B | -$6.64B | -$6.30B | -$6.03B | -$6.03B |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Retained Earnings | -$7.73B | -$6.31B | -$5.98B | -$5.72B | -$5.72B |
| Gains/Losses Not Affecting Retained Earnings | -$350.00M | -$334.00M | -$327.00M | -$305.00M | -$305.00M |
| Minority Interests | $3.48B | $3.43B | $3.33B | $3.26B | $3.26B |
| -Total Tax Payable | – | – | – | $504.00M | $504.00M |
| -Current Capital Lease Obligation | – | – | – | $352.00M | $352.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.46B | $2.34B | $2.01B | $12.64B | $2.36B |
| Net cash flow from continuing operations | $4.46B | $2.34B | $2.01B | $12.64B | $2.36B |
| Net Income from Continuing Operations | $1.85B | $1.93B | $1.86B | $7.78B | $2.16B |
| Gain/Loss from Continuing Operations | -$13.00M | -$10.00M | $1.00M | -$37.00M | -$41.00M |
| Depreciation & Depletion & Amortization | $954.00M | $944.00M | $930.00M | $3.52B | $911.00M |
| Deferred Tax | -$171.00M | -$166.00M | $435.00M | $310.00M | -$1.00B |
| Other Non-Cash Items | $50.00M | $61.00M | $78.00M | $239.00M | $61.00M |
| Change in Working Capital | $1.66B | -$509.00M | -$1.37B | $418.00M | $169.00M |
| -Change in Receivables | $782.00M | -$954.00M | -$463.00M | -$94.00M | -$439.00M |
| -Change in Inventory | $108.00M | -$106.00M | $80.00M | -$154.00M | -$29.00M |
| -Change in Payables and Accrued Expense | $769.00M | $551.00M | -$990.00M | $666.00M | $637.00M |
| Net cash flow from investing | -$1.92B | -$1.56B | -$1.28B | -$4.99B | -$1.32B |
| Net Cash Flow from Continuing Investing Activities | -$1.92B | -$1.56B | -$1.28B | -$4.99B | -$1.32B |
| Net PPE Purchase and Sale | -$1.36B | -$1.23B | -$1.12B | -$4.94B | -$1.49B |
| Net Business Purchase and Sale | -$470.00M | -$103.00M | -$262.00M | -$128.00M | $56.00M |
| Net Investment Purchase and Sale | -$94.00M | -$223.00M | $103.00M | $72.00M | $98.00M |
| Net Other Investing Changes | $5.00M | $0.00 | -$4.00M | $12.00M | $18.00M |
| Financing Cash Flow | -$2.65B | -$704.00M | -$830.00M | -$8.55B | -$999.00M |
| Net Cash Flow from Continuing Financing Activities | -$2.65B | -$704.00M | -$830.00M | -$8.55B | -$999.00M |
| Net Issuance Payments Of Debt | $723.00M | $1.69B | $1.38B | $3.29B | $1.98B |
| Net Common Stock Issuance | -$2.97B | -$2.06B | -$1.57B | -$10.07B | -$2.56B |
| Cash Dividends Paid | -$165.00M | -$171.00M | -$183.00M | -$679.00M | -$162.00M |
| Net Other Financing Charges | -$237.00M | -$157.00M | -$453.00M | -$1.09B | -$261.00M |
| Ending Cash Balance | $908.00M | $1.01B | $940.00M | $1.04B | $1.04B |
| Net Change in Cash | -$104.00M | $74.00M | -$98.00M | -$902.00M | $43.00M |
| Beginning Cash Balance | $1.01B | $940.00M | $1.04B | $1.93B | $997.00M |
| Effect of Exchange Rate Changes | -$1.00M | -$1.00M | -$2.00M | $9.00M | $0.00 |
| Free Cash Flow | $3.10B | $1.10B | $895.00M | $7.69B | $870.00M |
No comments yet — be the first to weigh in on HCA.
Sign in to join the discussion.